Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 15, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
September 19, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $25.47 $254,700.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,716

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.33 to $25.98, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 19, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $23.90 $239,000.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,716

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.14 to $24.80, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 21:36 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-24-041062 · wk-form4_1726868175.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:45 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 267 $25.12 $6,707.04
Disclosure

SEC source: 0001628280-24-040834 · wk-form4_1726695926.xml · nonDerivative · entry 3

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,568

F3 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:45 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 367 $25.12 $9,219.04
Disclosure

SEC source: 0001628280-24-040833 · wk-form4_1726695916.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,158

F3 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:45 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 229 $25.12 $5,752.48
Disclosure

SEC source: 0001628280-24-040831 · wk-form4_1726695897.xml · nonDerivative · entry 4

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,903

F4 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:45 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 343 $25.12 $8,616.16
Disclosure

SEC source: 0001628280-24-040832 · wk-form4_1726695906.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,716

F3 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:44 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 611 $25.12 $15,348.32
Disclosure

SEC source: 0001628280-24-040830 · wk-form4_1726695887.xml · nonDerivative · entry 3

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,388

F3 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:44 UTC
Richardson GarrieChief Revenue Officer
SaleCommon Stock 3,070 $25.12 $77,118.40
Disclosure

SEC source: 0001628280-24-040829 · wk-form4_1726695878.xml · nonDerivative · entry 1

Richardson Garrie · CIK 0001999183 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,773

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-01-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 21, 2024 Filed Sep 18, 2024 21:45 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 96 $25.61 $2,458.56
Disclosure

SEC source: 0001628280-24-040834 · wk-form4_1726695926.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,835

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 21, 2024 Filed Sep 18, 2024 21:45 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 82 $25.61 $2,100.02
Disclosure

SEC source: 0001628280-24-040833 · wk-form4_1726695916.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,525

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 21, 2024 Filed Sep 18, 2024 21:45 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 64 $25.61 $1,639.04
Disclosure

SEC source: 0001628280-24-040831 · wk-form4_1726695897.xml · nonDerivative · entry 3

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,132

F3 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 21, 2024 Filed Sep 18, 2024 21:45 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 111 $25.61 $2,842.71
Disclosure

SEC source: 0001628280-24-040832 · wk-form4_1726695906.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,059

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
August 21, 2024 Filed Sep 18, 2024 21:44 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 142 $25.61 $3,636.62
Disclosure

SEC source: 0001628280-24-040830 · wk-form4_1726695887.xml · nonDerivative · entry 2

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,999

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 19, 2024 Filed Sep 18, 2024 21:45 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 300 $21.01 $6,303.00
Disclosure

SEC source: 0001628280-24-040831 · wk-form4_1726695897.xml · nonDerivative · entry 2

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,196

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 18, 2024 Filed Sep 18, 2024 21:45 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 240 $22.50 $5,400.00
Disclosure

SEC source: 0001628280-24-040834 · wk-form4_1726695926.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,931

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 11, 2024 Filed Sep 18, 2024 21:45 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 287 $20.54 $5,894.98
Disclosure

SEC source: 0001628280-24-040833 · wk-form4_1726695916.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,607

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 11, 2024 Filed Sep 18, 2024 21:45 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 187 $20.54 $3,840.98
Disclosure

SEC source: 0001628280-24-040831 · wk-form4_1726695897.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,496

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 11, 2024 Filed Sep 18, 2024 21:45 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 313 $20.54 $6,429.02
Disclosure

SEC source: 0001628280-24-040832 · wk-form4_1726695906.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,170

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 11, 2024 Filed Sep 18, 2024 21:44 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 828 $20.54 $17,007.12
Disclosure

SEC source: 0001628280-24-040830 · wk-form4_1726695887.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,141

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 21:02 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 3,000 $21.03 $63,090.00
Disclosure

SEC source: 0001628280-24-031167 · wk-form4_1720040550.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,683

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.72 to $21.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 10,000 $20.18 $201,800.00
Disclosure

SEC source: 0001628280-24-028838 · wk-form4_1718744412.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,894

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.24, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 29, 2024 Filed May 31, 2024 21:05 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 408 $21.78 $8,886.24
Disclosure

SEC source: 0001628280-24-026084 · wk-form4_1717189544.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,171

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 29, 2024 Filed May 31, 2024 21:05 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 345 $21.78 $7,514.10
Disclosure

SEC source: 0001628280-24-026083 · wk-form4_1717189531.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,683

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 29, 2024 Filed May 31, 2024 21:05 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 517 $21.78 $11,260.26
Disclosure

SEC source: 0001628280-24-026082 · wk-form4_1717189519.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,483

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 29, 2024 Filed May 31, 2024 21:05 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 345 $21.78 $7,514.10
Disclosure

SEC source: 0001628280-24-026080 · wk-form4_1717189493.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,894

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 29, 2024 Filed May 31, 2024 21:05 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 574 $21.78 $12,501.72
Disclosure

SEC source: 0001628280-24-026081 · wk-form4_1717189506.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,969

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 12:13 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 98 $22.18 $2,173.64
Disclosure

SEC source: 0001628280-24-024448 · wk-form4_1716293607.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,000

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 12:13 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 73 $22.18 $1,619.14
Disclosure

SEC source: 0001628280-24-024449 · wk-form4_1716293618.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,239

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 12:13 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 57 $22.18 $1,264.26
Disclosure

SEC source: 0001628280-24-024445 · wk-form4_1716293573.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,028

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 12:13 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 115 $22.18 $2,550.70
Disclosure

SEC source: 0001628280-24-024447 · wk-form4_1716293596.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,543

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 12:13 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 85 $22.18 $1,885.30
Disclosure

SEC source: 0001628280-24-024446 · wk-form4_1716293584.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,579

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
May 15, 2024 Filed May 17, 2024 20:34 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 10,000 $22.67 $226,700.00
Disclosure

SEC source: 0001628280-24-024094 · wk-form4_1715978057.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,312

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.52 to $22.81, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 30, 2024 Filed May 2, 2024 21:05 UTC
Casdin Eli10% owner
OtherCommon Stock, par value $.001 per share 150,000 $17.54 $2,631,000.00
Disclosure

SEC source: 0000919574-24-002732 · ownership.xml · nonDerivative · entry 2

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · kind: Represents a cross-trade, pursuant to which a client of Casdin Capital, LLC ("Casdin Capital") transferred 150,000 shares of common Stock, par value $.001 per share to Casdin Partners Master Fund, L.P. (the "Master Fund").

F3 · ownership.nature: The securities were owned directly by a client of Casdin Capital and were deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin GP, the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
April 30, 2024 Filed May 2, 2024 21:05 UTC
Casdin Eli10% owner
OtherCommon Stock, par value $.001 per share 150,000 $17.54 $2,631,000.00
Disclosure

SEC source: 0000919574-24-002732 · ownership.xml · nonDerivative · entry 1

Casdin Partners Master Fund, L.P. · CIK 0001534265 · 10% owner

Casdin Capital, LLC · CIK 0001534261 · 10% owner

Casdin Partners GP, LLC · CIK 0001534260 · 10% owner

Casdin Eli · CIK 0001534264 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,707,165

F1 · kind: Represents a cross-trade, pursuant to which a client of Casdin Capital, LLC ("Casdin Capital") transferred 150,000 shares of common Stock, par value $.001 per share to Casdin Partners Master Fund, L.P. (the "Master Fund").

F2 · ownership.direct: The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Read SEC document
April 22, 2024 Filed Apr 23, 2024 23:15 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 410 $16.50 $6,765.00
Disclosure

SEC source: 0001628280-24-017499 · wk-form4_1713914088.xml · nonDerivative · entry 2

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,085

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 18, 2024 Filed Apr 23, 2024 23:15 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 348 $15.31 $5,327.88
Disclosure

SEC source: 0001628280-24-017499 · wk-form4_1713914088.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,495

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 18, 2024 Filed Apr 23, 2024 23:14 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 481 $15.31 $7,364.11
Disclosure

SEC source: 0001628280-24-017498 · wk-form4_1713914077.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,664

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 18, 2024 Filed Apr 23, 2024 23:14 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 584 $15.31 $8,941.04
Disclosure

SEC source: 0001628280-24-017497 · wk-form4_1713914064.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,098

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 18, 2024 Filed Apr 23, 2024 23:14 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 332 $15.31 $5,082.92
Disclosure

SEC source: 0001628280-24-017496 · wk-form4_1713914052.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,312

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 18, 2024 Filed Apr 23, 2024 23:14 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 956 $15.31 $14,636.36
Disclosure

SEC source: 0001628280-24-017495 · wk-form4_1713914040.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,658

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 15, 2024 Filed Apr 18, 2024 12:18 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 10,000 $15.67 $156,700.00
Disclosure

SEC source: 0001628280-24-016673 · wk-form4_1713442689.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,644

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:17 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 4,000 $17.65 $70,600.00
Disclosure

SEC source: 0001628280-24-014662 · wk-form4_1712179040.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,843

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-15-2023.

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:40 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 454 $17.99 $8,167.46
Disclosure

SEC source: 0001628280-24-013830 · wk-form4_1711748386.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 319,682

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:39 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 395 $17.99 $7,106.05
Disclosure

SEC source: 0001628280-24-013828 · wk-form4_1711748356.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,145

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:39 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 515 $17.99 $9,264.85
Disclosure

SEC source: 0001628280-24-013829 · wk-form4_1711748369.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,644

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.